Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Chao Jie, Zhen"'
Autor:
Vidya Balagopal, Andrew Hantel, Sabah Kadri, George Steinhardt, Chao Jie Zhen, Wenjun Kang, Pankhuri Wanjari, Lauren L Ritterhouse, Wendy Stock, Jeremy P Segal
Publikováno v:
PLoS ONE, Vol 14, Iss 10, p e0224097 (2019)
Improved systems for detection of measurable residual disease (MRD) in acute myeloid leukemia (AML) are urgently needed, however attempts to utilize broad-scale next-generation sequencing (NGS) panels to perform multi-gene surveillance in AML post-in
Externí odkaz:
https://doaj.org/article/4e003646ec644bfb9cfe7194a95a5ed0
Autor:
Ravi K. Amaravadi, Lisa E. Davis, Phyllis A. Gimotty, Jeremy P. Segal, Sabah Kadri, Chao Jie Zhen, Taehyong Kim, Anusha Kalavacharla, Angelique Onorati, Xiaowei Xu, Melissa Wilks, Maryann Redlinger, Mark Stein, Leonard J. Appleman, Naomi B. Haas
Supplemental Figures 1 and 2 (S1. Measurement of autophagic vesicles in PBMC and S2 Massively parallel sequencing and outcome.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80059cd2f0c13b3518f1367699514395
https://doi.org/10.1158/1078-0432.22472088
https://doi.org/10.1158/1078-0432.22472088
Autor:
Ravi K. Amaravadi, Lisa E. Davis, Phyllis A. Gimotty, Jeremy P. Segal, Sabah Kadri, Chao Jie Zhen, Taehyong Kim, Anusha Kalavacharla, Angelique Onorati, Xiaowei Xu, Melissa Wilks, Maryann Redlinger, Mark Stein, Leonard J. Appleman, Naomi B. Haas
Purpose:Everolimus inhibits the mTOR, activating cytoprotective autophagy. Hydroxychloroquine inhibits autophagy. On the basis of preclinical data demonstrating synergistic cytotoxicity when mTOR inhibitors are combined with an autophagy inhibitor, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce2c578552b72ce41f6c6c57fb1d258e
https://doi.org/10.1158/1078-0432.c.6528114.v1
https://doi.org/10.1158/1078-0432.c.6528114.v1
Autor:
George Steinhardt, Shira Fishbach, Rutika Puranik, Nicole A. Cipriani, Jeremy P. Segal, Chao Jie Zhen
Publikováno v:
Head Neck Pathol
In the absence of clear pathologic differences, clinical history may differentiate potential primary parotid squamous cell carcinomas (SCC) from metastases. The presence of an ultraviolet (UV) signature can distinguish between tumors of cutaneous and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45a2f2f3a4bc967c5b6f80690626b203
https://doi.org/10.1007/s12105-021-01349-x
https://doi.org/10.1007/s12105-021-01349-x
Autor:
Leonard Joseph Appleman, Angelique Onorati, Naomi B. Haas, Sabah Kadri, Phyllis A. Gimotty, Ravi K. Amaravadi, Taehyong Kim, Chao Jie Zhen, Xiaowei Xu, Mark N. Stein, Melissa Wilks, Jeremy P. Segal, Maryann Redlinger, Anusha Kalavacharla, Lisa E. Davis
Publikováno v:
Clin Cancer Res
Purpose: Everolimus inhibits the mTOR, activating cytoprotective autophagy. Hydroxychloroquine inhibits autophagy. On the basis of preclinical data demonstrating synergistic cytotoxicity when mTOR inhibitors are combined with an autophagy inhibitor,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d07bf27df3390fbebf09002aa0f85a1
https://doi.org/10.1158/1078-0432.ccr-18-2204
https://doi.org/10.1158/1078-0432.ccr-18-2204
Autor:
Moiz Bootwalla, Joshua L. Deignan, Tracy M. Busse, Gordana Raca, James Done, Jonathan D. Buckley, Chao Jie Zhen, Jaclyn A. Biegel, Xinjie Xu, Xiaowu Gai, Beverly Barton Rogers, David M. Parham, Alexander R. Judkins, Alex Ryutov, Matthew C. Hiemenz, Amanda L. Treece, Dennis T. Maglinte, Timothy J. Triche, Jianling Ji, Jeffrey M. Conroy, Dejerianne Ostrow, Florette K. Hazard
Publikováno v:
The Journal of Molecular Diagnostics. 20:765-776
The OncoKids panel is an amplification-based next-generation sequencing assay designed to detect diagnostic, prognostic, and therapeutic markers across the spectrum of pediatric malignancies, including leukemias, sarcomas, brain tumors, and embryonal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c74746d74304092851575f9a08acca74
https://doi.org/10.1016/j.jmoldx.2018.06.009
https://doi.org/10.1016/j.jmoldx.2018.06.009
Autor:
Jeremy P. Segal, Michelle N. Wurst, Chao Jie Zhen, Bradley C. Long, Ibro Mujacic, Nicole A. Cipriani, Larissa V. Furtado, Sabah Kadri, Tatjana Antic, Daniel Johnson
Publikováno v:
Archives of Pathology & Laboratory Medicine. 142:838-850
Context.—Proposed noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTPs), formerly noninvasive encapsulated papillary carcinoma, follicular variant (PTC-FV), is an indolent tumor with follicular growth and frequent RA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40d8d771513a6766b1de9ec01e69d28a
https://doi.org/10.5858/arpa.2017-0118-oa
https://doi.org/10.5858/arpa.2017-0118-oa
Autor:
Sabah Kadri, David Montes, Filippo Galbo, David T. Rubin, Jeremy P. Segal, Shu-Yuan Xiao, Lindsay Yassan, John Hart, Namrata Setia, Christopher R. Weber, Joel Pekow, Ibro Mujacic, Russell D. Cohen, Sushant A. Patil, Chao Jie Zhen, Lindsay Alpert, Michelle N. Wurst, Nifang Niu, Rachel Poon
Publikováno v:
Human pathology. 89
Inflammatory bowel disease-associated colorectal carcinomas (IBD-CRCs) develop in a background of chronic inflammation, and thus, the molecular landscape of these tumors likely differs from that of sporadic colorectal cancer. To add to emerging data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b328c822958627cb9cd897fb1cd9025
https://pubmed.ncbi.nlm.nih.gov/31054900
https://pubmed.ncbi.nlm.nih.gov/31054900
Autor:
Matthew C, Hiemenz, Dejerianne G, Ostrow, Tracy M, Busse, Jonathan, Buckley, Dennis T, Maglinte, Moiz, Bootwalla, James, Done, Jianling, Ji, Gordana, Raca, Alex, Ryutov, Xinjie, Xu, Chao Jie, Zhen, Jeffrey M, Conroy, Florette K, Hazard, Joshua L, Deignan, Beverly B, Rogers, Amanda L, Treece, David M, Parham, Xiaowu, Gai, Alexander R, Judkins, Timothy J, Triche, Jaclyn A, Biegel
Publikováno v:
The Journal of molecular diagnostics : JMD. 20(6)
The OncoKids panel is an amplification-based next-generation sequencing assay designed to detect diagnostic, prognostic, and therapeutic markers across the spectrum of pediatric malignancies, including leukemias, sarcomas, brain tumors, and embryonal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::db54eb88a55b69b688c41adf4d0d3b85
https://pubmed.ncbi.nlm.nih.gov/30138724
https://pubmed.ncbi.nlm.nih.gov/30138724
Autor:
Wenjun, Kang, Sabah, Kadri, Rutika, Puranik, Michelle N, Wurst, Sushant A, Patil, Ibro, Mujacic, Sonia, Benhamed, Nifang, Niu, Chao Jie, Zhen, Bekim, Ameti, Bradley C, Long, Filipo, Galbo, David, Montes, Crystal, Iracheta, Venessa L, Gamboa, Daisy, Lopez, Michael, Yourshaw, Carolyn A, Lawrence, Dara L, Aisner, Carrie, Fitzpatrick, Megan E, McNerney, Y Lynn, Wang, Jorge, Andrade, Samuel L, Volchenboum, Larissa V, Furtado, Lauren L, Ritterhouse, Jeremy P, Segal
Publikováno v:
The Journal of molecular diagnostics : JMD. 20(4)
Next-generation sequencing (NGS) diagnostic assays increasingly are becoming the standard of care in oncology practice. As the scale of an NGS laboratory grows, management of these assays requires organizing large amounts of information, including pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::64661ee42a17b7face242b530892f390
https://pubmed.ncbi.nlm.nih.gov/29698836
https://pubmed.ncbi.nlm.nih.gov/29698836